Pathos
Pathos is at the forefront of a novel approach to AI-driven drug development. This approach harnesses multimodal data, cutting-edge Artificial Intelligence, and profound clinical understanding to expedite the introduction of new therapies for patients. With an emphasis on Artificial Intelligence, clinical development, and implementation, Pathos is dedicated to enhancing patient outcomes by speeding up the transition from molecule to medicine.
HQ: New York, New York, United States
Country: USA

Establishment Year:
2020

Company Stage:
Mature

Estimated Employees:
51 .. 100

Estimated Revenues
$M 6.50

Raised Funding:
$M 447.00

AI Categories: